Skip to main content

Table 1 Patient demographics, comorbidities, and clinical variables of dead and alive patients

From: Deep learning of longitudinal chest X-ray and clinical variables predicts duration on ventilator and mortality in COVID-19 patients

 

Patients, no. (%)

 

Died (n = 76)

Survived (n = 110)

p value

Demographics

   

 Age, median (IQR)

67 (58, 73)

56 (50, 64)

 < 0.001

 Sex

  

0.117

  Male

59 (77.6%)

74 (67.3%)

 

  Female

17 (22.3%)

36 (32.7%)

 

 Ethnicity

  

0.374

  Hispanic/Latino

20 (26.3%)

35 (31.8%)

 

  Non-Hispanic/Latino

44 (57.9%)

61 (55.5%)

 

  Unknown

12 (15.8%)

14 (12.7%)

 

Comorbidities

   

 Smoking history

  

0.036

  Current smoker

4 (5.3%)

3 (2.7%)

 

  Former smoker

21 (27.6%)

14 (12.7%)

 

  Never smoker

46 (60.5%)

86 (78.2%)

 

  Unknown

5 (6.6%)

7 (6.4%)

 

 Diabetes

25 (32.9%)

32 (29.1%)

0.585

 Hypertension

46 (60.5%)

45 (40.9%)

0.008

 Asthma

7 (9.2%)

12 (10.9%)

0.705

 COPD

7 (9.2%)

6 (5.5%)

0.348

 Coronary artery disease

18 (23.7%)

8 (7.3%)

0.004

 Heart failure

6 (7.9%)

3 (2.7%)

0.141

 Cancer

3 (3.9%)

3 (2.7%)

0.656

 Immunosuppression

2 (2.6%)

9 (8.2%)

0.086

 Chronic kidney disease

5 (6.6%)

6 (5.5%)

0.755

Laboratory findings at admission, median (IQR)

   

 Alanine aminotransferase, U/L (alt)

43 (24, 71)

43 (25, 80)

0.194

 C-reactive protein, mg/dL (crp)

10.6 (4.9, 19.5)

5.3 (1.6, 12.1)

 < 0.001

 D-dimer, ng/mL (ddim)

1574 (793, 3290)

887 (498, 1894)

 < 0.001

 Ferritin, ng/mL (fer)

1267 (776, 2149)

861 (478, 1432)

 < 0.001

 Lactate dehydrogenase, U/L (ldh)

540 (411, 696)

392.0 (298, 512)

 < 0.001

 White blood cells, × 103/ml (wbc)

13.0 (8.9, 19.3)

10.9 (8.4, 14.3)

 < 0.001

 Lymphocytes, % (lym)

4.5 (2.1, 8.0)

8.9 (4.5, 15.0)

 < 0.001

 Procalcitonin, ng/mL (procal)

0.7 (0.3, 1.9)

0.2 (0.1, 0.6)

0.019

 Troponin T, ng/mL (tnt)

0.0 (0.0, 0.1)

0.0 (0.0, 0.0)

 < 0.001

 Aspartate aminotransferase, U/L (ast)

49.0 (32.0, 76.0)

38.0 (25.0, 63.0)

0.005

 Creatinine, mg/dL (crt)

1.4 (0.9, 2.7)

0.8 (0.6, 1.3)

 < 0.001

Blood gases and others

   

 pCO2

48.0 (42.0, 57.0)

47.0 (40.0, 53.0)

0.020

 HCO3

26.0 (22.0, 31.0)

26.8 (23.0, 31.0)

0.113

 pH

7.3 (7.3, 7.4)

7.4 (7.3, 7.4)

 < 0.001

 pO2

78.0 (64.9, 99.0)

82.7 (69.0, 105.0)

0.001

 Hematocrit (hcrit)

31.2 (26.7, 37.0)

31.7 (27.4, 37.7)

 < 0.001

 Potassium, mEq/L (k)

4.3 (3.9, 4.9)

4.1 (3.7, 4.5)

 < 0.001

 Sodium, mEq/L (Na)

141.0 (137.0, 147.0)

141.0 (138.0, 145.0)

 < 0.001

Vital signs, median (IQR)

   

 Heart Rate, bpm (hr)

86.0 (72.0, 101.0)

84.0 (71.0, 97.0)

 < 0.001

 Respiratory rate, bpm (rr)

25.0 (20.0, 30.0)

23.0 (20.0, 27.0)

 < 0.001

 Oxygen saturation (o2)

96.0 (93.0, 98.0)

97.0 (94.0, 99.0)

 < 0.001

 Systolic blood pressure, mmHg (sbp)

122.0 (109.0, 138.0)

124.0 (111.0, 142.0)

0.008

 Diastolic blood pressure, mmHg (dbp)

64.0 (58.0, 72.0)

67.0 (60.0, 76.0)

0.005

 Mean arterial pressure, mmHg (map)

84.0 (77.0, 95.0)

88.0 (79.0, 98.0)

 < 0.001

 Temperature, °C (temp)

37.0 (36.7, 37.5)

36.9 (36.7, 37.2)

 < 0.001

 FiO2, %

70.0 (50.0, 90.0)

50.0 (40.0, 60.0)

 < 0.001

  1. The clinical variables were averaged across five time points and then averaged across subjects (median, IQR)